Skip to main content

colorectal cancer Archives

Calcium intake and colorectal cancer

Oct. 18, 2017—Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered.

Read more


Researchers find novel mechanism of resistance to anti-cancer drugs

Oct. 17, 2017—Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance.

Read more


Fatty acids and adenoma risk

Aug. 21, 2017—Vanderbilt researchers have found that red blood cell membrane fatty acid content is associated with risk of having colorectal adenomas, with omega-6 fatty acids increasing and omega-3 fatty acids decreasing risk.

Read more


Coffey lands major NCI award to support colorectal cancer research

Jun. 8, 2017—Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer.

Read more


Study seeks to reverse precancerous stomach lesions

May. 4, 2017—Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions.

Read more


Nanobeacon lights up colon tumors

Mar. 30, 2017—A novel fluorescent nanobeacon can distinguish normal from diseased colon tissue, potentially offering advantages for colorectal cancer screening.

Read more


Study takes 3-D perspective on colorectal cancer

Mar. 23, 2017—Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus.

Read more


New target for colorectal cancer

Mar. 17, 2017—Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

Read more


Concert by singer Wade Hayes and friends to benefit VICC

Feb. 15, 2017—Country music artist and cancer survivor Wade Hayes will host the second annual “Country Hits Back” benefit concert March 7 at the Franklin Theatre. The event will support vitally important cancer research at Vanderbilt-Ingram Cancer Center.

Read more


Colorectal cancer clues

Jan. 19, 2017—Although cancers arising from different areas of the large intestine are heterogeneous, they appear to use similar important tumorigenic pathways.

Read more


An Argonaute’s voyage to cancer

Apr. 28, 2016—A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.”

Read more


One Million Strong event to raise awareness about colorectal cancer

Mar. 17, 2016—Thousands of colorectal patients, families and supporters will gather in Nashville April 1 and 2 for the annual One Million Strong event to raise awareness about colorectal cancer.

Read more


Page 1 of 3123

Upcoming Events

MORE EVENTS »